Women Home > Yasmin and Breastfeeding

In general, healthcare providers almost always recommend that women use a progestin-only oral contraceptive instead of combined oral contraceptives (such as Yasmin) when breastfeeding. Although no studies have been done on Yasmin and breastfeeding, it is known that the hormones in the drug do pass through breast milk. There is some concern that some of these hormones could cause problems in male infants.

Is Yasmin Safe During Breastfeeding?

Yasmin® (drospirenone/ethinyl estradiol) is a combined oral contraceptive, which contains both a progestin and an estrogen. In general, combined oral contraceptives (including Yasmin) are not recommended for breastfeeding women.
(Ocella™, Syeda™, and Zarahbirth control pills are generic versions of Yasmin. The information in this article applies to Ocella, Syeda, and Zarah as well.)

What Does the Research Say About Yasmin and Breastfeeding?

Studies have shown that the hormones in Yasmin do pass through breast milk in low amounts. These tiny amounts are probably too low to cause significant problems in breastfeeding infants, although this has not been confirmed by any studies. However, there is some concern that Yasmin could cause problems in male infants, because drospirenone (one of the hormones in Yasmin) counteracts the effects of testosterone and other male hormones. Also, there have been reports of problems, such as breast enlargement and jaundice, in babies whose mothers took other combined oral contraceptives while breastfeeding.
Perhaps more importantly, combined oral contraceptives may decrease the production and quality of breast milk. For this reason, healthcare providers almost always recommend progestin-only oral contraceptives (also known as "mini-pills") instead of combined contraceptives for women who are breastfeeding. However, progestin-only contraceptive pills are usually less effective than combined contraceptives. As soon as you stop breastfeeding, it may be a good idea to ask your healthcare provider about switching to a combined contraceptive product such as Yasmin.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.